The FDA estimates the PreCheck program could save participating companies up to 14 months by reviewing facilities while they ...

SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves ...

TORONTO, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...

FDA’s PreCheck Pilot Program aims to de-risk and accelerate domestic capacity buildouts via earlier regulatory interaction, aligning manufacturing policy with supply-chain resilience priorities.

As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...

Aligned with the FDA on submitted protocol for 225Ac-PSMA (FPI-2265) Phase 2/3 registrational program for patients with metastatic castration-resistant prostate cancer (mCRPC) Achieved target ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) released results from a neurotoxicity study of Ketamir-2, its novel oral NMDA receptor antagonist, on Tuesday. The U.S. Food and Drug Administration (FDA) ...

IRVING, Texas & DENVER--(BUSINESS WIRE)--Vizient Inc. and RISCS, Inc. today announced a joint pilot program aimed at enhancing assurance of pharmaceutical supply. Once implemented, the program would ...

Boston, August 17, 2015 — It is with great honor that Teva Pharmaceuticals announces the re-establishment of the Teva Pharmaceuticals Scholars Grants Program as the Teva Pharmaceuticals Marc A. Goshko ...

Purdue University’s Lilly Scholars are hitting the ground running in their training to become the next generation of pharmaceutical manufacturing talent. Thanks to a $42.5 million collaboration ...